/Investor DB

dievini Hopp BioTech holding GmbH & Co. KG

Venture capital

1 people tracked

Find your way into dievini Hopp BioTech holding GmbH & Co. KG

Sign up to see every warm intro you have to dievini Hopp BioTech holding GmbH & Co. KG

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the dievini Hopp BioTech holding GmbH & Co. KG team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

dievini backs life and health sciences companies pursuing novel therapeutic and diagnostic approaches with the potential to enable entirely new treatment forms, aiming to give physicians and patients more effective and better-tolerated therapies in mostly life-threatening indications. Portfolio companies focus on oncology, plus neurology, infectious diseases, cell therapy and improved drug formulation. In molecular diagnostics, the emphasis is on personalized-medicine systems and products that improve individual therapy outcomes while reducing side effects. Geographically, dievini concentrates on Germany and Europe while supporting companies in their global development and commercialization.

Source: firm website, verified Aug 3, 2026.

Instruments
Equity

Team · 1 people

from the firm's website

Frequently asked questions

What sectors does dievini Hopp BioTech holding GmbH & Co. KG focus on?
dievini Hopp BioTech holding GmbH & Co. KG focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.

Similar investors

Featured in lists